LexaGene Introduces its Commercial Product MiQLab™ Automated, genetic analyzer designed for rapid, point-of-need testing

BEVERLY, Mass., July13, 2020(GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the "Company"), a molecular diagnostics company that develops genetic analyzers for rapid pathogen detection, is pleased to announce the name and first look of the Company's flagship product, called MiQLab™, which can be seen on the Company's website, and is being manufactured for an anticipated commercial launch prior to the end of September 2020. Read More